Is Apellis Pharmaceuticals, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Apellis Pharmaceuticals, Inc. has changed from bullish to sideways. The current technical stance is neutral, with a mildly bearish outlook on the weekly MACD and KST, while the monthly MACD shows a mildly bullish signal. However, both the weekly and monthly Bollinger Bands indicate a bearish trend. Daily moving averages are mildly bullish, but overall, the indicators suggest a lack of strong momentum in either direction.
In terms of performance, the stock has significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -32.72% compared to the S&P 500's 16.30%, and a one-year return of -21.24% against the S&P 500's 19.89%.